Overactive bladder (OAB) is often treated with medications that block the cholinergic
receptors in the bladder (known as anticholinergics). The effect of this medication class on …

Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

Overactive bladder syndrome (OAB) is defined as urinary urgency, usually accompanied by
frequency and nocturia, with or without urgency incontinence, in the absence of urinary tract …

Anticholinergics have been used in the treatment of overactive bladder (OAB), but their use
is limited by poor tolerability and anticholinergic-related side effects. Increasingly, providers …

Introduction Overactive bladder (OAB) is a common condition, increasing with age and
affecting quality of life. While numerous OAB drugs are available, persistence is low. We …

Ageing is associated with deteriorating urinary bladder function and an increasing
prevalence of disorders such as underactive bladder. There are suggestions that G protein …

Objective To determine if OAB anticholinergics have an increased risk of delirium or
falls/fractures relative to OAB beta‐3 agonist medications. Methods This was a retrospective …

Objectives This analysis from the PERSPECTIVE (a Prospective, Non‐interventional
Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder) study …

With many common bladder diseases arising due to abnormal contractions, a greater
understanding of the receptor systems involved may aid the development of future …

Aims Two phase 1 trials were performed in healthy women with the overactive bladder
(OAB) syndrome and urodynamically demonstrated detrusor overactivity (DO), with the aim …